article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Although medicines tend to be excluded from trade sanctions as they cause loss of life, Russian pharma companies may struggle to secure funding in the face of economic sanctions and there may also be a disruption to non-essential medicines. million vaccine doses upon EMA authorisation.

article thumbnail

The immediate future of DTC

World of DTC Marketing

Once vaccination levels reach critical mass, people will once again return to their physician’s offices. Let’s be clear about pharma product websites. In short, online health seekers aren’t finding compelling reasons to ask for your product on your website. Having just a website is not enough.

Doctors 296
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharma companies, however, operate manufacturing sites in the country.

article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

In light of the Covid-19 pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for onshoring, also referred to as reshoring; the bringing back of pharma production to locations within national borders to mitigate costs, supply issues, and concerns regarding bilateral relations.

article thumbnail

How pharmaceutical firms are making their supply chains more efficient

Pharmaceutical Technology

The value of real-time data Amid unprecedented instability in lockdown-stricken supply chains, digital transformation company Controlant helped to safely deliver more than 5 billion COVID-19 vaccines. So we’ve got a standard process that we’re executing quite a few times throughout the life cycle of the product itself.”